These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22166948)

  • 1. 8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndrome.
    Talseth-Palmer BA; Scott RJ; Vasen HF; Wijnen JT
    Eur J Hum Genet; 2012 May; 20(5):487-8; author reply 488. PubMed ID: 22166948
    [No Abstract]   [Full Text] [Related]  

  • 2. Colorectal cancer susceptibility loci on chromosome 8q23.3 and 11q23.1 as modifiers for disease expression in Lynch syndrome.
    Talseth-Palmer BA; Brenne IS; Ashton KA; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; Spigelman A; Lubinski J; Scott RJ
    J Med Genet; 2011 Apr; 48(4):279-84. PubMed ID: 21097774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 8q23.3 and 11q23.1 variants modify colorectal cancer risk in Lynch syndrome.
    Wijnen JT; Brohet RM; van Eijk R; Jagmohan-Changur S; Middeldorp A; Tops CM; van Puijenbroek M; Ausems MG; Gómez García E; Hes FJ; Hoogerbrugge N; Menko FH; van Os TA; Sijmons RH; Verhoef S; Wagner A; Nagengast FM; Kleibeuker JH; Devilee P; Morreau H; Goldgar D; Tomlinson IP; Houlston RS; van Wezel T; Vasen HF
    Gastroenterology; 2009 Jan; 136(1):131-7. PubMed ID: 19010329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers.
    Houlle S; Charbonnier F; Houivet E; Tinat J; Buisine MP; Caron O; Benichou J; Baert-Desurmont S; Frebourg T
    Eur J Hum Genet; 2011 Aug; 19(8):887-92. PubMed ID: 21407259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined analysis of three Lynch syndrome cohorts confirms the modifying effects of 8q23.3 and 11q23.1 in MLH1 mutation carriers.
    Talseth-Palmer BA; Wijnen JT; Brenne IS; Jagmohan-Changur S; Barker D; Ashton KA; Tops CM; Evans TJ; McPhillips M; Groombridge C; Suchy J; Kurzawski G; ; Spigelman A; Møller P; Morreau HM; Van Wezel T; Lubinski J; Vasen HF; Scott RJ
    Int J Cancer; 2013 Apr; 132(7):1556-64. PubMed ID: 22987364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
    Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
    Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient mismatch repair testing in colorectal cancer: more than just screening for Lynch syndrome.
    West NP
    Colorectal Dis; 2019 Jun; 21(6):621-622. PubMed ID: 31152577
    [No Abstract]   [Full Text] [Related]  

  • 9. SNP association study in PMS2-associated Lynch syndrome.
    Ten Broeke SW; Elsayed FA; Pagan L; Olderode-Berends MJW; Garcia EG; Gille HJP; van Hest LP; Letteboer TGW; van der Kolk LE; Mensenkamp AR; van Os TA; Spruijt L; Redeker BJW; Suerink M; Vos YJ; Wagner A; Wijnen JT; Steyerberg EW; Tops CMJ; van Wezel T; Nielsen M
    Fam Cancer; 2018 Oct; 17(4):507-515. PubMed ID: 29147930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
    Kravochuck SE; Church JM
    ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
    Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
    Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the reported modifying effect of 8q23.3 and 11q23.1 on colorectal cancer risk for MLH1 mutation carriers valid?
    Win AK; Jenkins MA
    Int J Cancer; 2013 Oct; 133(7):1762-3. PubMed ID: 23536426
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on Hereditary Colorectal Cancer.
    DA Silva FC; Wernhoff P; Dominguez-Barrera C; Dominguez-Valentin M
    Anticancer Res; 2016 Sep; 36(9):4399-405. PubMed ID: 27630275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome.
    Tresallet C; Brouquet A; Julié C; Beauchet A; Vallot C; Ménégaux F; Mitry E; Radvanyi F; Malafosse R; Rougier P; Nordlinger B; Laurent-Puig P; Boileau C; Emile JF; Muti C; Penna C; Hofmann-Radvanyi H
    Int J Cancer; 2012 Mar; 130(6):1367-77. PubMed ID: 21520036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
    Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
    Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility genetic variants associated with early-onset colorectal cancer.
    Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
    Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome?
    Germini DE; Mader AM; Gomes LG; Teodoro TR; Franco MI; Waisberg J
    Tumour Biol; 2016 Feb; 37(2):2757-64. PubMed ID: 26408182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome).
    Lynch HT; Lynch JF; Lynch PM
    J Natl Cancer Inst; 2007 Feb; 99(4):261-3. PubMed ID: 17312298
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
    Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
    Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.